- Eye Diseases and Conditions Slideshow Pictures
- Pink Eye Slideshow Pictures
- Eyes and Eye Conditions Quiz
- Patient Comments: Herpes of the Eye - Treatment
- Patient Comments: Herpes of the Eye - Symptoms at Time of Diagnosis
- Patient Comments: Herpes of the Eye - How it Develops
- Find a local Eye Doctor in your town
- What are herpes viruses?
- Which types of herpes viruses can affect the eyes?
- What parts of the eyes are susceptible to herpes viruses?
- Who is at risk for herpes infections of the eyes?
- What are the signs and symptoms of herpes eye infections?
- How are herpes eye infections diagnosed?
- How are herpes eye infections treated?
- What are the possible risks and complications of untreated herpes eye infections?
- What is the prognosis of herpes eye infections?
- Can herpes eye infections be prevented?
Can herpes eye infections be prevented?
For patients with frequent recurrences of herpes eye infections, taking a low dose antiviral drug on a daily basis can, in some cases, reduce the frequency of recurrences. Your doctors will help determine if this is a safe option.
There is no vaccine against HSV at this time. There is a vaccine against chickenpox for babies and toddlers (varicella vaccine). For adults over 60 years of age, the zoster vaccine may reduce the frequency and severity of recurrences of shingles and HZV eye disease. Research is ongoing to develop a means of eradicating the virus in its latent state.
Farooq, A. V., et al. "Herpes simplex epithelial and stromal keratitis: an epidemiologic update." Survey of Ophthalmology 57.5 (2012): 448-462.
Liesegang, T. J. "Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity." Ophthalmology 115.2 Suppl (2008): S3-S12.
Oxman, M. N., et al. "Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults." New England Journal of Medicine 352.22 (2005): 2271-2284.
van Rooij, J., et al. "Effect of acyclovir after penetrating keratoplasty for herpatic keratitis: a placebo-controlled multicenter trial." Ophthalmology 110.10 (2003): 1916-1919.